2023-09-08T10:34:23-05:00 2022-12-31 410746749 CLIFTONLARSONALLEN LLP 150 S WARNER ROAD SUITE 310 KING OF PRUSSIA PA 19406 990 2022-01-01 223369741 INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH INTE 6095864981 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 ROBERT ABBOTT CEO & EXECUTIVE DIRECTOR 6095864981 2023-08-24 1 ROBERT ABBOTT 999009999 0 WILLIAM A LOUGHERY P01603932 2156433900 2023-08-24 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z ROBERT ABBOTT 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 20488139 0 X WWW.ISPOR.ORG X 1995 NJ PROMOTE GLOBAL HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING 12 11 53 900 11600 602 35000 40000 5799586 14205222 1128508 157836 1091524 189942 8054618 14593000 0 0 0 0 5688236 6900605 0 0 0 3879018 8256369 9567254 15156974 -1512636 -563974 24515564 23939884 1485391 4053006 23030173 19886878 X THE MISSION OF INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH (ISPOR) IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY. 0 0 12509207 0 14193622 ISPOR IS A NON-PROFIT GLOBAL SCIENTIFIC AND EDUCATIONAL ORGANIZATION WITH APPROXIMATELY 9,296 MEMBERS, WHO ARE INVOLVED IN HEALTHCARE OUTCOMES RESEARCH (INCLUDING CLINICAL, ECONOMIC AND PATIENT-REPORTED OUTCOMES) OF HEALTH TECHNOLOGIES (DRUGS, DEVICES, DIAGNOSTICS) AND SERVICES OR THE USE OF OUTCOMES RESEARCH IN HEALTHCARE DECISIONS. THE MISSION OF ISPOR IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY. ISPOR IS FUNDED THROUGH ITS MEETINGS, TRAINING COURSES AND MEMBERSHIP DUES. THROUGH ITS MULTIPLE MEETINGS EACH YEAR, ISPOR PROVIDES A FORUM TO FACILITATE THE INTERCHANGE OF SCIENTIFIC KNOWLEDGE IN PHARMACOECONOMICS /HEALTH ECONOMICS AND OUTCOMES RESEARCH, HEALTH POLICY AND THE USE OF THIS RESEARCH IN HEALTHCARE DECISIONS.ISPOR PUBLISHES TWO SCIENTIFIC JOURNALS, ONE HEOR NEWS MAGAZINE, AND FOUR ELECTRONIC NEWSLETTERS. ISPOR DEVELOPS CONSENSUS DOCUMENTS (GOOD PRACTICES/GUIDELINES) ON OUTCOMES RESEARCH METHODS OR USE OF THIS RESEARCH IN HEALTHCARE DECISIONS. ISPOR FOSTERS EDUCATION AND THE DEVELOPMENT OF OUTCOMES RESEARCH AT THE LOCAL LEVEL WITH ITS REGIONAL CHAPTERS AND STUDENT CHAPTERS GLOBALLY TO PROMOTE THE SCIENCE OF PHARMACOECONOMICS/HEALTH ECONOMICS AND HEALTH OUTCOMES RESEARCH WORLDWIDE. ISPOR HELD TWO IN-PERSON/VIRTUAL CONFERENCES (NORTH AMERICAN & ERUOPEAN) INCLUDING 4,000 SCIENTIFIC PRESENTATIONS. IN 2022, ISPOR PUBLISHED 3,122 PAGES OF OUTCOMES RESEARCH AND HEALTH POLICY PAPERS IN ITS THREE JOURNALS: VALUE IN HEALTH, VALUE IN HEALTH REGIONAL ISSUES AND VALUE & OUTCOMES SPOTLIGHT. AT THE CLOSE OF 2022 ISPOR HAD OVER 9,296 MEMBERS FROM 111 COUNTRIES, 144 STUDENT CHAPTERS AND OVER 83 REGIONAL CHAPTERS AROUND THE WORLD. THROUGH ISPOR TASK FORCES, COUNCILS AND SPECIAL INTEREST GROUPS, ISPOR HAS DEVELOPED 'TOOLS' FOR OUTCOMES RESEARCHERS, SUCH AS GOOD PRACTICES FOR OUTCOMES RESEARCH WITH OVER 1,000,000 DOWNLOADS ANNUALLY AND A WEB-BASED DATABASE OF OVER 64,000 RESEARCH PRESENTATIONS GIVEN AT ISPOR MEETINGS. 12509207 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 56 0 53 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 12 11 0 0 0 0 1 1 0 1 1 0 1 1 0 1 1 1 1 1 1 0 0 NJ X JILL CHEN 6095864981 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE NJ 08648 NANCY S BERG CEO & EXECUTIVE DIRECTOR 40.00 X X 598736 0 27204 JANS ELIAS HANSEN PHD PRESIDENT (SINCE JULY 2022) 2.00 X X 0 0 0 BRIAN O'ROURKE PRESIDENT-ELECT (SINCE JULY 2022) 2.00 X X 0 0 0 ISAO KAME DRPH MD PAST PRESIDENT 2.00 X X 0 0 0 SEAN SULLIVAN MSC PHD TREASURER 2.00 X X 0 0 0 DAVID THOMPSON PHD DIRECTOR 2.00 X 0 0 0 EBERECHUKWU ONUKWUGHA PHD DIRECTOR 2.00 X 0 0 0 BETH DEVINE PHD DIRECTOR 2.00 X 0 0 0 MARLENE GYLDMARK MPHIL DIRECTOR 2.00 X 0 0 0 ANDREA MANCA MSC PHD DIRECTOR 2.00 X 0 0 0 DONG-CHURL SUH PHD DIRECTOR 2.00 X 0 0 0 LOTTE STEUTEN MPHIL DIRECTOR 2.00 X 0 0 0 JENS GRUEGER PHD PAST PRESIDENT (LEFT JUNE 2022) 2.00 X X 0 0 0 JILL CHEN DIRECTOR, FINANCE 40.00 X 119600 0 11503 SUSAN CAPON CHIEF OPERATING OFFICER 40.00 X 280985 0 25858 THAD LURIE CHIEF INFORMATION OFFICER 40.00 X 207595 0 20970 ELIZABETH LANE CHIEF MARKETING OFFICER 40.00 X 195059 0 20853 LAURA PIZZI ASSOCIATE CHIEF SCIENCE OFFICER 40.00 X 192519 0 7050 PAUL WONG DIRECTOR, GLOBAL EVENTS 40.00 X 184154 0 11049 SEAN GORMLEY ASSOCIATE DIRECTOR, SALES 40.00 X 197942 0 20780 1976590 0 145267 17 0 1 0 FREEMAN 1600 VICEROY DRIVE SUITE 100 DALLAS TX 75235 AUDIO VISUAL 694589 AUSTRIA CENTER VIENNA BRUNO-KREISKY-PLATZ 1 1220 WEIN AU 21128 CONFERENCE VENUE 690489 MARRIOTT HOTEL SERVICES INC DBA GAYLOR 201 WATERFRONT STREET NATIONAL HARBOR MD 20769 CONFERENCE VENUE 615204 FINANZAMT OSTERREICH AUSTRIAN TAX OFFICE PO BOX 260 AUSTRIA VIENNA AU 21128 AUSTRIAN VAT AUTHORITY 599814 AETNA 151 FARMINGTON AVENUE HARTFORD CT 06156 MEDICAL BENEFITS 446101 13 40000 40000 MEETING REVENUE 611430 11010606 11010606 EBULLETIN/TECH JOURNAL REVENUE 541900 1387007 1375407 11600 MEMBER SERVICES 611430 1070780 1070780 EDUCATION AND SCIENTIFIC REVENUE 541900 736829 736829 14205222 412832 412832 86579 24164 62415 62415 62415 5615979 5870975 -254996 -254996 -254996 REBATES AND COMMISSIONS 900099 93754 93754 WIRE TRANSFER FEES 900099 18773 18773 STRATEGIC SPONSORSHIP 900099 15000 15000 127527 14593000 14193622 11600 347778 1063886 396430 667456 4786201 3741314 1044887 248941 189356 59585 399808 299054 100754 401769 285997 115772 325711 313301 12410 122773 118095 4678 75495 75495 599196 576756 22440 397705 283103 114602 103350 73569 29781 3825270 3825270 234614 167008 67606 45288 32238 13050 JOURNAL/EDITORIAL 586648 586648 OTHER COMMUNICATION 570836 508914 61922 STAFF DEVELOPMENT 431274 306999 124275 BANK AND CREDIT CARD CH 374969 266919 108050 563240 538236 25004 15156974 12509207 2647767 0 817280 2602648 1283285 741395 179772 1346131 466152 307497 4470868 1503686 3038955 2967182 18730120 15975031 24515564 23939884 1039201 1966626 438800 2078990 7390 7390 1485391 4053006 X 23030173 19886878 23030173 19886878 24515564 23939884 -563974 -2579321 0 X 0 1 X 1 0 X 904564 210000 105000 35000 40000 1294564 14730663 15903323 4601894 5787986 14193622 55217488 15635227 16113323 4706894 5822986 14233622 56512052 0 0 0 56512052 341347 402812 398597 445058 499411 2087225 341347 402812 398597 445058 499411 2087225 10586 7372 2381 1500 602 22441 9243204 19494 127527 9390225 15987160 16523507 14351076 6289038 14861162 68011943 0.83090 0.83530 0.03070 0.02780 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: INSURANCE PROCEEDS - 2020 AMOUNT: $ 9,243,204. BAD DEBT RECOVERY - 2021 AMOUNT: $ 19,494. STRATEGIC SPONSORSHIP - 2022 AMOUNT: $ 15,000. WIRE TRANSFER FEE - 2022 AMOUNT: $ 18,773. REBATES AND COMMISSIONS - 2022 AMOUNT: $ 93,754. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 400000 400000 2579292 705981 1873311 1491576 797705 693871 2967182 SECURITY DEPOSIT 7390 7390 X 11938184 -2579321 -2579321 14517505 75495 75495 14593000 15081479 0 15081479 75495 75495 15156974 PART X, LINE 2: ISPOR IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). HOWEVER, INCOME FROM CERTAIN ACTIVITIES NOT DIRECTLY RELATED TO ISPOR'S TAX-EXEMPT PURPOSE IS SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. ISPOR FOLLOWS THE INCOME TAX STANDARD FOR UNCERTAIN TAX POSITIONS. ISPOR BELIEVES THERE ARE NO UNCERTAIN TAX POSITIONS THAT ARE REQUIRED TO BE DISCLOSED IN THE FINANCIAL STATEMENTS. EUROPE (INCLUDING ICELAND & GREENLAND) 0 1 PROGRAM SERVICE ANNUAL EUROPEAN MEETING 2184450 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICE ANNUAL MEETING 5194 0 1 0 0 0 1 2189644 0 2189644 0 0 0 0 0 0 PART III ACCOUNTING METHOD: X X X X 0 0 0 0 0 0 0 1 0 NANCY S BERG CEO & EXECUTIVE DIRECTOR 598736 0 0 0 0 0 18300 0 8904 0 625940 0 0 0 SUSAN CAPON CHIEF OPERATING OFFICER 243573 0 37412 0 0 0 16954 0 8904 0 306843 0 0 0 THAD LURIE CHIEF INFORMATION OFFICER 207595 0 0 0 0 0 3715 0 17255 0 228565 0 0 0 SEAN GORMLEY ASSOCIATE DIRECTOR, SALES 91851 0 106091 0 0 0 11876 0 8904 0 218722 0 0 0 ELIZABETH LANE CHIEF MARKETING OFFICER 180309 0 14750 0 0 0 11950 0 8903 0 215912 0 0 0 LAURA PIZZI ASSOCIATE CHIEF SCIENCE OFFICER 192519 0 0 0 0 0 7050 0 0 0 199569 0 0 0 PAUL WONG DIRECTOR, GLOBAL EVENTS 166154 0 18000 0 0 0 11049 0 0 0 195203 0 0 0 PART I, LINE 7 THE BONUSES WERE PART OF THE ANNUAL BUDGET WHICH WAS APPROVED BY THE BOARD OF DIRECTORS. THESE AMOUNTS ARE INCLUDED IN EACH RECIPIENT'S 2022 FORM W-2. THE FOLLOWING EMPLOYEES RECEIVED BONUSES IN 2022: SUSAN CAPON: $37,412 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. ELIZABETH LANE: $14,750 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. SEAN GORMLEY: $8,720 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. $97,371 OF INCENTIVE BASED COMPENSATION. PAUL WONG: $18,000 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. JILL CHEN: $5,000 DISCRETIONARY BONUS BASED ON PERSONAL PERFORMANCE AND SUBJECT TO APPROVAL BY THE CEO & EXECUTIVE DIRECTOR. FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE HAS THE DUTIES AND AUTHORITY BETWEEN MEETINGS OF THE BOARD, IN PLACE OF THE BOARD, TO TAKE ACTION ON MATTERS CONSISTENT WITH THE GOALS OF THE SOCIETY. THE EXECUTIVE COMMITTEE IS COMPRISED OF THE OFFICERS OF THE SOCIETY: PRESIDENT, IMMEDIATE PAST PRESIDENT, PRESIDENT-ELECT, EXECUTIVE DIRECTOR (AS SECRETARY) AND TREASURER. THE EXECUTIVE DIRECTOR IS A VOTING MEMBER OF THE BOARD, EXCEPT ON THE MATTER OF THE EXECUTIVE DIRECTOR'S SALARY AND CONTRACT REVIEW AND DETERMINATION. FORM 990, PART VI, SECTION A, LINE 6 THE SOCIETY HAS FIVE TYPES OF MEMBERS AS FOLLOWS: MEMBER - ANY INDIVIDUAL WHO SUPPORTS THE OBJECTIVES OF THE SOCIETY AND IS WILLING TO CONTRIBUTE TO THE ACHIEVEMENT OF THOSE OBJECTIVES IS ELIGIBLE FOR MEMBERSHIP. STUDENT MEMBER - ANY INDIVIDUAL FORMALLY ENROLLED IN A PROGRAM OF STUDY WHICH INCLUDES ASPECTS OF HEALTH ECONOMICS OR HEALTH OUTCOMES RESEARCH IN THE STUDY CURRICULUM AND SUPPORTS THE MISSION OF THE SOCIETY IS ELIGIBLE FOR STUDENT MEMBERSHIP. STUDENT MEMBERS ARE NOT PERMITTED TO HOLD OFFICER OR DIRECTOR POSITIONS. FELLOW - ANY MEMBER WHO IS DEEMED TO HAVE MADE A MERITORIOUS CONTRIBUTION TO THE ADVANCEMENT OF HEALTH ECONOMICS AND/OR OUTCOMES RESEARCH AS DEFINED BY THE ISPOR BOARD. NEW PROFESSIONAL - ANY INDIVIDUAL WITH THREE YEARS OR LESS PROFESSIONAL EXPERIENCE IN HEALTH ECONOMICS OR OUTCOMES RESEARCH. RETIRED MEMBERS - ANY MEMBER WITH TEN OR MORE YEARS OF PAID ISPOR MEMBERSHIP AND WORKING LESS THAN HALF TIME (TWENTY OR FEWER HOURS PER WEEK). FORM 990, PART VI, SECTION A, LINE 7A MEMBERS, STUDENT MEMBERS, FELLOWS, NEW PROFESSIONALS, AND RETIRED MEMBERS HAVE THE RIGHT TO VOTE FOR BOARD OFFICERS AND DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B THE ISPOR FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM. THE REVIEW OF THE FORM 990 BEFORE FILING IS DELEGATED TO THE CEO, EXECUTIVE DIRECTOR, AND DIRECTOR OF FINANCE BY THE BOARD OF DIRECTORS. THE COMPLETED FORM 990 IS AVAILABLE FOR REVIEW BY THE BOARD OF DIRECTORS AND THE MEMBERSHIP AFTER FILING. FORM 990, PART VI, SECTION B, LINE 12C TO INSURE COMPLIANCE WITH THE ORGANIZATION'S CONFLICT OF INTEREST POLICY, BOARD MEMBERS, OFFICERS AND EMPLOYEES AGREE TO COMPLY WITH THE POLICY BY COMPLETING AND SIGNING A CONFLICT OF INTEREST STATEMENT. EVERY YEAR THE BOARD HAS THE RESPONSIBILITY OF ENSURING COMPLIANCE WITH THE POLICY, ADMINISTERING THE ANNUAL QUESTIONNAIRE AND MAKING DECISIONS AS REQUIRED TO AVOID ACTUAL CONFLICT OF INTEREST. THE BOARD ALSO REVIEWS AND REVISES THIS POLICY AS NEEDED IN THE EVENT OF AN ACTUAL CONFLICT OF INTEREST OR THE APPEARANCE OF A CONFLICT OF INTEREST, INTERESTED PARTY MUST DISCLOSE THE NATURE OF THE CONFLICT AND HE/SHE SHALL NOT BE PRESENT IN THE BOARD OR COMMITTEE DELIBERATIONS OR VOTE ON THE MATTER. COMPLETED CONFLICT OF INTEREST FORMS ARE INCLUDED ON BOARD AGENDAS, AND RECORDED IN THE BOARD MINUTES. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE COMMITTEE, EXCLUDING THE EXECUTIVE DIRECTOR, CONDUCTS AN ANNUAL REVIEW OF THE EXECUTIVE DIRECTOR'S PERFORMANCE INCLUDING ACCOMPLISHMENTS VERSUS PRE-SPECIFIED GOALS AS WELL AS THE PERFORMANCE OF THE ORGANIZATION. BENCHMARKING OF THE COMPENSATION OF THE EXECUTIVE DIRECTOR IS DETERMINED USING ASSOCIATION CHIEF STAFF EXECUTIVE COMPENSATION SURVEYS BY THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVES (ASAE). COMPENSATION OF THE EXECUTIVE DIRECTOR IS ALSO DETERMINED WITH THE USE OF COMPENSATION SURVEYS AND THE FORM 990 OF SIMILAR ORGANIZATIONS. THE EXECUTIVE COMMITTEE NEGOTIATES AN EMPLOYMENT AGREEMENT WITH THE EXECUTIVE DIRECTOR AND THEN DETERMINES THE EXECUTIVE DIRECTOR'S COMPENSATION, THROUGH A FORMAL VOTE IN PRIVATE SESSIONS, WITHOUT THE EXECUTIVE DIRECTOR'S PRESENCE. THE FINAL AGREEMENT AND SALARY DETERMINATION IS DOCUMENTED IN A TIMELY COMMUNICATION FROM THE PRESIDENT ON BEHALF OF THE EXECUTIVE COMMITTEE AUTHORIZING THE EXECUTIVE DIRECTOR'S COMPENSATION. THIS COMMUNICATION IS RETAINED WITH THE ISPOR PAYROLL RECORDS. FORM 990, PART VI, SECTION C, LINE 19 ISPOR MAKES ITS FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS AVAILABLE UPON WRITTEN REQUESTS SUBMITTED TO ISPOR'S ADDRESS.